MAP2K7 and hepatocellular carcinoma: Interestingly, after overexpression of PSMD12 in HCC cells, we found that the proliferation, migration and invasion capabilities of tumor cells were improved, and treatment with the ERK pathway inhibitor U0126 inhibited the activation of the MEK-ERK signaling pathway and reversed the malignant phenotype of tumor cells to a certain extent.